Literature DB >> 6282934

Human skin collagenase in recessive dystrophic epidermolysis bullosa. Purification of a mutant enzyme from fibroblast cultures.

G P Stricklin, H G Welgus, E A Bauer.   

Abstract

Recessive dystrophic epidermolysis bullosa, a genodermatosis characterized by dermolytic blister formation in response to minor trauma, is characterized by an incresaed collagenase synthesis by skin fibroblasts in culture. Since preliminary studies of partially purified recessive dystrophic epidermolysis bullosa collagenase suggested that the protein itself was aberrant, efforts were made to purify this enzyme to homogeneity, so that detailed biochemical and immunologic comparisons could be made with normal human skin fibroblast collagenase. Recessive dystrophic epidermolysis bullosa skin fibroblasts obtained from a patient documented to have increased synthesis of the enzyme were grown in large scale tissue culture and both serum-free and serum-containing medium collected as a source of collagenase. The recessive dystrophic epidermolysis bullosa collagenase was purified to electrophoretic homogeneity using a combination of salt precipitation, ion-exchange, and gel-filtration chromatography. In contrast to the normal enzyme, the recessive dystrophic epidermolysis bullosa collagenase bound to carboxymethyl-cellulose at Ca(2+) concentrations at least 10 times higher than those used with the normal enzyme. Additionally, this enzyme was significantly more labile to chromatographic manipulations, particularly when serum-free medium was used. However, rapid purification from serum-containing medium yielded a preparation enzymatically equivalent to normal human skin collagenase. Like the normal enzyme, the recessive dystrophic epidermolysis bullosa collagenase was secreted as a set of two closely related zymogens of approximately 60,000 and approximately 55,000 daltons that could be activated by trypsin to form enzymically active species of approximately 50,000 and approximately 45,000 daltons, respectively. Amino acid analysis suggested slight variations between the normal and recessive dystrophic epidermolysis bullosa collagenases. Cyanogen bromide digests demonstrated peptides unique to the enzyme from each source. The recessive dystrophic epidermolysis bullosa proenzyme was significantly more thermolabile at 60 degrees C than the normal, a finding that correlated with an approximate fourfold decrease in the affinity of the mutant enzyme for Ca(2+), a known activator and stabilizer of human skin collagenase. Aside from the altered affinity for this metal cofactor, kinetic analysis of the structurally altered recessive dystrophic epidermolysis bullosa collagenase revealed that its reaction rates and substrate specificity for human collagen types I-V were identical to those for the normal enzyme. Likewise, enzymes from both sources displayed identical energies of activation and deuterium isotope effects. Antisera were raised to the normal and putatively mutant procollagenases respectively, and, although they displayed a reaction of identity in double diffusion analysis, immunologic differences were present in enzyme inhibition and quantitative precipitation studies. These studies indicate that recessive dystrophic epidermolysis bullosa is characterized by the increased synthesis of an enzymically normal, but structurally aberrant, collagenase.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6282934      PMCID: PMC370210          DOI: 10.1172/jci110577

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Collagenase and connective tissue metabolism in epidermolysis bullosa.

Authors:  G S Lazarus
Journal:  J Invest Dermatol       Date:  1972-04       Impact factor: 8.551

2.  Human skin collagenase: relationship to the pathogenesis of epidermolysis bullosa dystrophica.

Authors:  A Z Eisen
Journal:  J Invest Dermatol       Date:  1969-05       Impact factor: 8.551

3.  Tadpole collagenase. Preparation and purification.

Authors:  Y Nagai; C M Lapiere; J Gross
Journal:  Biochemistry       Date:  1966-10       Impact factor: 3.162

4.  Spectrophotometric determination of microgram quantities of protein without nucleic acid interference.

Authors:  W E Groves; F C Davis; B H Sells
Journal:  Anal Biochem       Date:  1968-02       Impact factor: 3.365

5.  Polypeptides of the tail fibres of bacteriophage T4.

Authors:  J King; U K Laemmli
Journal:  J Mol Biol       Date:  1971-12-28       Impact factor: 5.469

6.  Enzymatic and immunochemical estimation of C'1 esterase inhibitor in sera from patients with hereditary angioneurotic edema.

Authors:  A B Laurell; J Lindegren; I Malmros; H Mårtensson
Journal:  Scand J Clin Lab Invest       Date:  1969-10       Impact factor: 1.713

7.  A pseudocholinesterase variant (E Cynthiana) associated with elevated plasma enzyme activity.

Authors:  A Yoshida; A G Motulsky
Journal:  Am J Hum Genet       Date:  1969-09       Impact factor: 11.025

8.  Purine overproduction in man associated with increased phosphoribosylpyrophosphate synthetase activity.

Authors:  M A Becker; L J Meyer; A W Wood; J E Seegmiller
Journal:  Science       Date:  1973-03-16       Impact factor: 47.728

9.  Amino acid substitution (histidine to tyrosine) in a glucose-6-phosphate dehydrogenase variant (G6PD Hektoen) associated with over-production.

Authors:  A Yoshida
Journal:  J Mol Biol       Date:  1970-09-28       Impact factor: 5.469

10.  Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema.

Authors:  F S Rosen; C A Alper; J Pensky; M R Klemperer; V H Donaldson
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

View more
  6 in total

1.  Stimulation of in vitro human skin collagenase expression by platelet-derived growth factor.

Authors:  E A Bauer; T W Cooper; J S Huang; J Altman; T F Deuel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

2.  Genetic linkage to the type VII collagen gene (COL7A1) in 26 families with generalised recessive dystrophic epidermolysis bullosa and anchoring fibril abnormalities.

Authors:  M G Dunnill; A J Richards; G Milana; F Mollica; D Atherton; I Winship; M Farrall; L al-Imara; R A Eady; F M Pope
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318

3.  Autoantibodies to extracellular collagen matrix components in epidermolysis bullosa and other bullous diseases.

Authors:  S Gay; J D Fine; J S Storer
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

4.  Proteases, dermal proliferation, keratinization and calcium.

Authors:  D P MacLeod
Journal:  J R Soc Med       Date:  1990-04       Impact factor: 18.000

5.  Exclusion of stromelysin-1, stromelysin-2, interstitial collagenase and fibronectin genes as the mutant loci in a family with recessive epidermolysis bullosa dystrophica and a form of cerebellar ataxia.

Authors:  M Colombi; R Gardella; N Zoppi; L Moro; D Marini; N K Spurr; S Barlati
Journal:  Hum Genet       Date:  1992-07       Impact factor: 4.132

6.  Exclusion of linkage between the collagenase gene and generalized recessive dystrophic epidermolysis bullosa phenotype.

Authors:  A Hovnanian; P Duquesnoy; S Amselem; C Blanchet-Bardon; M Lathrop; L Dubertret; M Goossens
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.